Beam Therapeutics Revenue 2019-2021 | BEAM

Beam Therapeutics annual/quarterly revenue history and growth rate from 2019 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Beam Therapeutics revenue for the quarter ending June 30, 2021 was $0.000B, a 0% increase year-over-year.
  • Beam Therapeutics revenue for the twelve months ending June 30, 2021 was $0.000B, a 0% increase year-over-year.
  • Beam Therapeutics annual revenue for 2020 was $0B, a 33.33% increase from 2019.
  • Beam Therapeutics annual revenue for 2019 was $0B, a INF% increase from 2018.
  • Beam Therapeutics annual revenue for 2018 was $0B, a NAN% decline from .
Beam Therapeutics Annual Revenue
(Millions of US $)
2020 $0
2019 $0
2018 $
Beam Therapeutics Quarterly Revenue
(Millions of US $)
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.180B $0.000B
Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00